Providence Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.41M Buy
+74,000
New +$7.09M 1.05% 43
2024
Q4
Sell
-8,700
Closed -$783K 240
2024
Q3
$783K Sell
8,700
-61,317
-88% -$5.16M 0.16% 87
2024
Q2
$5.51M Buy
70,017
+70,000
+411,765% +$5.74M 1.2% 37
2024
Q1
$1.48K Sell
17
-62,083
-100% -$5.3M ﹤0.01% 307
2023
Q4
$5.12M Buy
62,100
+6,600
+12% +$503K 1.23% 36
2023
Q3
$4.35M Buy
+55,500
New +$4.65M 1.14% 42
2023
Q2
Sell
-56,100
Closed -$4.52M 318
2023
Q1
$4.52M Buy
56,100
+8,500
+18% +$693K 1.2% 40
2022
Q4
$3.73M Sell
47,600
-200
-0.4% -$16.2K 1.01% 47
2022
Q3
$3.89M Buy
47,800
+4,400
+10% +$395K 1.17% 35
2022
Q2
$3.92M Buy
43,400
+3,200
+8% +$324K 1.14% 29
2022
Q1
$4.46M Buy
40,200
+40,175
+160,700% +$4.24M 1.09% 32
2021
Q4
$3K Hold
25
﹤0.01% 298
2021
Q3
$3K Hold
25
﹤0.01% 272
2021
Q2
$3K Sell
25
-82
-77% -$10.3K ﹤0.01% 277
2021
Q1
$13K Hold
107
﹤0.01% 193
2020
Q4
$13K Buy
107
+82
+328% +$9.03K 0.01% 205
2020
Q3
$3K Buy
+25
New +$2.51K ﹤0.01% 189
2020
Q2
Sell
-100
Closed -$9K 226
2020
Q1
$9K Buy
+100
New +$10.6K 0.01% 175
2019
Q3
Sell
-30,600
Closed -$2.98M 241
2019
Q2
$2.98M Buy
30,600
+30,525
+40,700% +$2.79M 1.77% 9
2019
Q1
$7K Buy
+75
New +$6.71K ﹤0.01% 198
2018
Q2
Sell
-24,100
Closed -$1.93M 254
2018
Q1
$1.93M Buy
24,100
+958
+4% +$79K 1.45% 20
2017
Q4
$1.87M Buy
+23,142
New +$1.85M 1.44% 23

Other funds holding MDT

Providence Capital Advisors's MDT Position: Q1 2026 in Review

Providence Capital Advisors opened a new position in Medtronic (MDT) in Q1 2026: 74,000 shares worth $6.41M. The stake represents 1.05% of the portfolio and ranks #43 among its holdings. This is a return to the name: Providence Capital Advisors previously reported a position in MDT as recently as Q3 2024.

Providence Capital Advisors first reported a position in MDT in Q4 2017 and has held it in 22 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Providence Capital Advisors held 74,000 shares of Medtronic worth $6.41M as of Q1 2026.
  • Medtronic was a new Providence Capital Advisors position in Q1 2026.
  • Medtronic made up 1.05% of Providence Capital Advisors's portfolio in Q1 2026, its #43 holding.
  • Providence Capital Advisors first reported a position in Medtronic in Q4 2017 and has held it in 22 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Providence Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.